The role of compatibility tests. (Report of a meeting sponsored by the Bureau of Biologics for the Blood Products Advisory Committee)
1982; Wiley; Volume: 22; Issue: 2 Linguagem: Inglês
10.1046/j.1537-2995.1982.22282177132.x
ISSN1537-2995
Autores Tópico(s)Blood transfusion and management
ResumoTransfusionVolume 22, Issue 2 p. 169-172 The role of compatibility tests. (Report of a meeting sponsored by the Bureau of Biologics for the Blood Products Advisory Committee) George Garratty, George Garratty American Red Cross Blood Services, Los Angeles-Orange Counties Region. Los Angeles. CASearch for more papers by this author George Garratty, George Garratty American Red Cross Blood Services, Los Angeles-Orange Counties Region. Los Angeles. CASearch for more papers by this author First published: March‐April 1982 https://doi.org/10.1046/j.1537-2995.1982.22282177132.xCitations: 27AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Mintz PD, Nordine RB, Henry JB, Webb WR Expected hemotherapy in elective surgery. NY St J Med, 1976, 76, 532– 37. 2 Friedman BA, Oberman HA, Chadwick AR, Kingdon KI The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion, 1976, 16, 380– 87. 3 Boral LI, Henry JB The type and screen: A safe alternative and supplement in selected surgical procedures. Transfusion, 1977, 17, 163– 68. 4 Oberman HA, Barnes BA, Friedman BA The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion, 1978, 18, 137– 41. 5 Grove-Rasmussen M. Routine compatibility testing. Transfusion, 1961, 4, 200– 5. 6 Oberman HA The crossmatch: past, present and future. In: CA Bell, ed. A seminar on immune-mediated cell destruction. Washington: American Association of Blood Banks 1981: 29– 44. 7 Mintz PD, Haines AL, Sullivan MF Incompatible crossmatch following nonreactive antibody detection test: frequency and cause. Transfusion, 1982, 22, 107– 110. 8 Rouault CL Appropriate pretransfusion testing. In: M. Treacy, ed. Pretransfusion testing for the '80s. Washington: American Association of Blood Banks 1980: 125– 32. 9 Dinman BD The reality and acceptance of risk. JAMA, 1980: 244: 1226– 28. 10 Taswell HF, Pineda AA, Moore SB Hemolytic transfusion reactions: frequency and clinical and laboratory aspects. In: CA Bell, ed. A seminar on immune-mediated cell destruction. Washington: American Association of Blood Banks 1981: 71– 92. 11 Mayer K. Transfusion safety - a different view. In: RH Walker, HF Polseky, eds. Safety in transfusion practice. Skokie, Illinois: College of American Pathologists 1982 (In press). 12 Ness PM, Rosche ME, Barrasso C., Luff RD, Johnson JWC Jr The efficiency of type and screen to reduce unnecessary crossmatches for obstetric patients. Am J Obstet Gynecol, 1981: 661– 64. 13 Winn JC, Svoboda R., Hafleigh EB, Grumet FC An extended antibody screen to replace the crossmatch. Transfusion, 1980, 20, 651 (abstract). 14 Svoboda R. Passing the crossmatch by screening antibodies. Lab World, 1982, 32, 26– 32. 15 Spivak M. The importance of compatibility testing. In: M. Treacy, ed. Pretransfusion testing for the '80s. Washington: American Association of Blood Banks 1980: 133– 39. 16 Galen RS, Gambino SR Beyond normality. New York: John Wiley & Sons 1975. 17 Trudeau LR, Judd WJ, Oberman HA Is a room temperature crossmatch necessary for the detection of ABO errors? Transfusion, 1981, 21, 625 (abstract). Citing Literature Volume22, Issue2March‐April 1982Pages 169-172 ReferencesRelatedInformation
Referência(s)